Risk.net

DrKW appoints new global head of equity-linked origination

Dresdner Kleinwort Wasserstein (DrKW), the US investment banking arm of Dresdner Bank, has appointed Ken Robbins as a managing director and global head of equity-linked origination.

    • Choongo Moonga
  • LinkedIn  
  • Save this article
  • Print this page  
Robbins was most recently co-head of equity capital markets for Australasia at Credit Suisse First Boston. He will be based in London and report to John St John, global head of capital markets.

The bank has also appointed Domenico Iuliano as director and senior bond trader in the euro flow trading team in Frankfurt. He will have market-making responsibilities for Germany, France, Italy and Spain, and joins DrKW from French bank Société Générale, where he worked as an arbitrage trader in European

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Copyright Infopro Digital Limited. All rights reserved.

As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.

If you would like to purchase additional rights please email info@risk.net

Copyright Infopro Digital Limited. All rights reserved.

You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.

If you would like to purchase additional rights please email info@risk.net

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Want to know what’s included in our free membership? Click here

More on People

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here